Urology Medical News about Testosterone

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine
Therapeutic Advances in Urology, 10/08/09

Aversa A et al. – The aim of this review is to show evidence on the role of T and PDE5 inhibitors, alone or in combination, as potential boosters of endothelial function in internal medicine diseases associated with reduced T or NO bioavailability, i.e. metabolic syndrome, obesity, diabetes, coronary artery disease, hyperhomocysteinemia, that share common risk factors with ED.

<< Previous
NBBS isolated from Pygeum africanum bark exhibits androgen...

Next >>
A phase I study of zibotentan (ZD4054) in patients with...

Safety and efficacy of testosterone gel in the treatment of male hypogonadism
Clinical Interventions in Aging, 10/12/09 Relevance Score: 95%

Testosterone and biological characteristics of breast cancers in postmenopausal women
Cancer Epidemiology, Biomarkers & Prevention, 10/28/09 Relevance Score: 94%

Testosterone supplementation: For whom and when?
Sexuality, Reproduction & Menopause, 10/08/09 Relevance Score: 93%

NIH-Supported Trial to Study Testosterone Therapy in Older Men
MedLinePlus, 11/04/09 Relevance Score: 91%

NIH-Supported Trial to Study Testosterone Therapy in Older Men
NIH, 11/03/09 Relevance Score: 91%